Futai, Rie <br/><br/>
Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.  [electronic resource] 

 -  Heart and vessels  Jul 2009 
 - 294-300 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1615-2573 
<br/><br/><label>Standard No.: </label>10.1007/s00380-008-1119-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amlodipine--therapeutic use<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Biomarkers--blood<br/>Blood Pressure--drug effects<br/>C-Reactive Protein--metabolism<br/>Calcium Channel Blockers--therapeutic use<br/>Echocardiography, Doppler, Color<br/>Female<br/>Fibrosis<br/>Humans<br/>Hypertension--diagnostic imaging<br/>Hypertrophy, Left Ventricular--diagnostic imaging<br/>Imidazoles--therapeutic use<br/>Inflammation--drug therapy<br/>Male<br/>Middle Aged<br/>Myocardium--pathology<br/>Severity of Illness Index<br/>Tetrazoles--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Ventricular Function, Left--drug effects